Clinical & Diagnostic

AGC Biologics Partners with Quell Therapeutics to Advance Treg Cell Therapies for Immune Disorders

-AGC Biologics, your friendly CDMO expert,  announced a partnership with Quell Therapeutics (“Quell”), a clinical-stage bio...

 May 19, 2025 | News

Agilent and Ubix Therapeutics Join Forces to Advance Targeted Cancer Therapies in South Korea

Research focuses on targeted protein degradation and antibody-drug conjugate as promising modalities for developing next-generation cancer therapies ...

 May 15, 2025 | News

Eligo Bioscience Secures $5M French Government Grant to Advance Topical Gene-Editing Platform

Funding is part of the call for proposals "Innovations in Biotherapies and Bioproduction," coordinated by the Health Innovation Agency under Fra...

 May 14, 2025 | News

Singapore Approves Dupixent as First Biologic Treatment for Uncontrolled COPD with Raised Eosinophils

  The Health Sciences Authority (HSA) has approved Dupixent (dupilumab) for adults as an add-on maintenance treatment for uncontrolled chronic obstru...

 May 14, 2025 | News

BD Launches FACSDiscover™ A8 Cell Analyzer to Expand Access to Advanced Spectral and Real-Time Imaging Technologies

  New BD FACSDiscover™ A8 Cell Analyzer Brings Leading-Edge Capabilities to Wider Range of Scientists across Academia and Biopharma BD (Becton...

 May 14, 2025 | News

Nordic Bioscience and Roche Launch Elecsys PRO-C3 Test to Advance Liver Fibrosis Assessment on cobas Analyzers

Nordic Bioscience announces that its PRO-C3 test is launched by Roche Diagnostics on their cobas analysers. The Roche Elecsys® PRO-C3, used w...

 May 09, 2025 | News

Connext Completes Phase 1 for CNT201, Eyes Phase 2 Launch and Expansion into Peyronie’s Disease

 Conducted under U.S. FDA-cleared IND– Plans for Phase 2 initiation in Q3 2025 and expansion into Peyronie's disease Connext, a clinical s...

 May 09, 2025 | News

Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific

Vision health is emerging as a critical but under-addressed component of public health in Asia Pacific. In a region where populations are rapidly ageing an...

 May 09, 2025 | Expert Insight

TiumBio’s Merigolix Shows Phase 2 Success in Asia for Uterine Fibroids

TiumBio (KRX: 321550.KQ), a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapeutics for patients with rare a...

 May 08, 2025 | News

Taiwan’s Formosa Pharmaceuticals Partners with Apotex to Commercialize APP13007 in Mexico for Post-Ocular Surgery Treatment

Taiwan-based Formosa Pharmaceuticals  announced  that the company has entered into an exclusive licensing agreement with Apotex Inc. ("Apotex"), ...

 May 07, 2025 | News

S&E bio Receives MFDS Approval for Korea’s First Clinical Trial of Exosome-Based Stroke Therapy

 S&E bio Co., Ltd., a biotechnology company specializing in exosomal microRNA-based therapies, has received approval from Korea's Ministry of Food...

 May 01, 2025 | News

Everest Medicines Secures Hong Kong Approval for VELSIPITY® in Ulcerative Colitis

Everest Medicines , a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeu...

 April 30, 2025 | News

Akeso’s Ivonescimab Outperforms Pembrolizumab in Phase III, Wins NMPA Approval for First-Line PD-L1-Positive NSCLC

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that its globally first-in-class PD-1/VEGF bispecific antibody, ivonescimab, has re...

 April 28, 2025 | News

Primo Biotechnology Secures PIC/S GMP and GDP Certifications, Strengthening Global Position in Nuclear Medicine

Primo Biotechnology Co., Ltd. ("Primo") proudly announces that its Taoyuan pharmaceutical facility has successfully passed inspection by Taiwan Food and Dr...

 April 25, 2025 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close